Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsAnimal biotechnology biotechnology Plant biotechnology Benefits of biotech crops GMOs Food biofuel agriculture Intellectual Property biotech industry BIO EVENT Sustainability global food crisis climate change BIOTECH BIO International Convention health Health Care Industry Analysis USPTO
- Most Popular